|

TCR-T cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1

Top Sponsors

  • Second Affiliated Hospital of Guangzhou Medical University1
  • Beijing Geekgene Technology Co., LTD1

Indications

  • Lung Cancer2
  • Cancer2
  • Nonsmall-cell Lung Cancer1
  • Triple Negative Breast Cancer (TNBC)1
  • Non-small Cell Lung Cancer (NSCLC)1

Other2 trials

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
Phase 1
a Single-arm, Single-center, Open Clinical Study

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.